CVS Group (LON:CVSG) Receives Buy Rating from Berenberg Bank

CVS Group (LON:CVSG)‘s stock had its “buy” rating reiterated by analysts at Berenberg Bank in a report released on Tuesday,London Stock Exchange reports. They presently have a GBX 2,000 price objective on the stock. Berenberg Bank’s price objective would indicate a potential upside of 76.99% from the stock’s current price.

Several other analysts have also recently commented on CVSG. Royal Bank Of Canada increased their target price on CVS Group from GBX 1,500 to GBX 1,900 and gave the stock an “outperform” rating in a report on Tuesday, October 21st. Jefferies Financial Group upped their price target on shares of CVS Group from GBX 1,250 to GBX 1,420 and gave the stock a “hold” rating in a research report on Wednesday, October 22nd. Peel Hunt reissued a “buy” rating and set a GBX 1,600 price objective on shares of CVS Group in a report on Tuesday. Finally, Deutsche Bank Aktiengesellschaft boosted their target price on shares of CVS Group from GBX 1,500 to GBX 1,700 and gave the stock a “buy” rating in a research note on Tuesday, October 21st. Four analysts have rated the stock with a Buy rating and one has assigned a Hold rating to the company. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of GBX 1,724.

CVS Group Stock Performance

Shares of LON CVSG remained flat at GBX 1,130 during mid-day trading on Tuesday. 1,633,670 shares of the stock traded hands, compared to its average volume of 393,365. CVS Group has a 12 month low of GBX 791 and a 12 month high of GBX 1,648. The firm’s fifty day moving average price is GBX 1,277.19 and its two-hundred day moving average price is GBX 1,256.11. The company has a debt-to-equity ratio of 110.52, a quick ratio of 0.90 and a current ratio of 1.09. The firm has a market cap of £809.03 million, a P/E ratio of 15.35, a P/E/G ratio of 1.77 and a beta of 1.02.

CVS Group (LON:CVSG) last released its quarterly earnings results on Tuesday, October 7th. The company reported GBX 80.10 EPS for the quarter. CVS Group had a return on equity of 7.86% and a net margin of 3.20%. As a group, equities research analysts predict that CVS Group will post 93.9393939 earnings per share for the current fiscal year.

Insider Activity

In other CVS Group news, insider Robin Alfonso purchased 870 shares of the stock in a transaction dated Monday, November 17th. The stock was bought at an average price of GBX 1,147 per share, for a total transaction of £9,978.90. Company insiders own 1.38% of the company’s stock.

CVS Group Company Profile

CVS Group plc, together with its subsidiaries, engages in veterinary, pet crematoria, online pharmacy, and retail businesses. The company operates through four segments: Veterinary Practices, Laboratories, Crematoria, and Online Retail Business. It operates in animal veterinary practices and complementary veterinary diagnostic businesses.